20
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Pathogenesis of Gallstones

Pages 577-582 | Published online: 08 Jul 2009

References

  • Diehl A K. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20: 1–19
  • Heaton K W., Braddon F EM, Mountford R A., Hughes A O., Emmett P M. Symptomatic and silent gall stones in the community. Gut 1991; 32: 316–20
  • Busch N, Matern S. Current concepts in cholesterol gallstone pathogenesis. Eur J Clin Invest 1991; 21: 453–60
  • Admiral W H., Small D M. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 1043–52
  • Teilum D. The prevalence of gallstones in autopsies from a Danish urban area. Acta Chir Scand 1989; 155: 103–6
  • Teilum D, Olsen B. Cholecystectomy rate in autopsies from a Danish urban area. Acta Chir Scand 1989; 155: 273–5
  • Bainton D, Davies G T., Evans K T., Gravelle I H. Gallbladder disease: prevalence in a South Wales industrial town. N Engl Med 1979; 294: 1147–9
  • Bennion U, Drobny E, Knowler W C., et al. Sex differences in the size of bile acid pools. Metabolism 1978; 27: 961–9
  • Jorgenscn T. Gallstones and plasma lipids in a Danish population. Scand J Gastroenterol 1989; 24: 916–22
  • Jensen K H., Jorgensen T. Incidence of gallstones in a Danish population. Gastroenterology 1991; 100: 790–4
  • Danzinger R G., Gordon H, Schoefield L J., Thistle J L. Lithogenic bile in siblings of young women with cholelithiasis. Mayo Clin Proc 1972; 47: 762–6
  • Grundy S M., Metzger A L., Adler R D. Mechanisms of lithogenic bile formation in American indian women with cholesterol gallstones. J Clin Invest 1972; 51: 3026–43
  • Einarsson K, Angelin B. Pathogenesis of cholesterol gallstone disease. The secretory defect. Bile acids in health and disease, T C. Northfield, R P. Jazrawi, P L. Zentler-Munro. Kluwer, Dordrecht 1988; 99–116
  • Bennion U, Grundy S M. Risk factors for the development of cholelithiasis in man. N Engl J Med 1978; 299: 1221–7
  • Maclure K M., Hayes K C., Colditz G A., Stampfer M J., Speizer F E., Willett W C. Weight diet and the risk of symptomatic gallstones in middle-aged women. N Engl J Med 1989; 321: 563–9
  • Liddle R A., Goldstein R B., Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149: 1750–3
  • Everson G T., McKinley C, Kern F, Jr. Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87: 237–46
  • Jorgensen T, Jorgensen L M. Gallstones and diet in a Danish population. Scand J Gastroenterol 1989; 24: 821–6
  • Petitti D B., Friedman G D., Klatsky A L. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 1981; 23: 1396–8
  • Scragg R KR, Calvert G D., Oliver J R. Plasma lipids and insulin in gall stone disease: a case-control study. Br Med J 1984; 289: 521–5
  • Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99: 843–9
  • Trotman B W., Ostrow J D., Soloway R D. With the technical assistance of Cheong EB, Longyear RB. Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974; 19: 585–90
  • Carey M C., Small D M. The physical chemistry of cholesterol solubility in bile: relationship to gallstone formation and dissolution in man. J Clin Invest 1978; 61: 998–1026
  • Trotman B W., Soloway R D. Pigment gallstone disease: summary of the National Institutes of Health-International Workshop. Hepatology 1982; 2: 879–84
  • Løtveit T. The composition of biliary calculi in patients with juxtapapillary duodenal diverticula. Scand J Gastroenterol 1982; 17: 653–6
  • Skar V, Lotveit T, Osnes M. Juxtapapillary duodenal diverticula predispose to common bile duct stones. Scand J Gastroenterol 1989; 24: 202–4
  • Skar V, Skar A G., Bratlie J, Osnes M. Beta-glucuronidase activity in the bile of gallstone patients with and without duodenal diverticula. Scand J Gastroenterol 1989; 24: 205–12
  • van Erpecum K J., van Berge Henegouwen G P., Stoelwinder B, Stolk M FJ, Eggink W F., Govaert W HA. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentation between the two stone types. Scand J Gastroenterol 1988; 23: 948–54
  • Ravnborg L, Teilum D, Pedersen L R. Gallbladder stones classified by chemical analysis of cholesterol content. Scand J Gastroenterol 1990; 25: 720–4
  • Juvonen T, Niemela O. ABO blood group and gallstone disease. Br Med J 1992; 307: 26–7
  • Mazer N A., Carey M C. Quasielastic light scattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions. Biochem 1983; 22: 426–42
  • Mazer N A., Benedek G B., Carey M C. Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. Biochemistry 1980; 19: 601–15
  • Sömjen G, Gilat T. A non-micellar mode of cholesterol transport in human bile. FEBS Lett 1983; 156: 265–8
  • Sömjen G, Gilat T. Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J Lipid Res 1985; 26: 699–704
  • Donovan J M., Timofeyeva N, Carey M C. Influence of total lipid concentration bile salt: lecithin ratio and cholesterol content on inter-mixed micellar/vesicular (non-lecithin-associated) bile salt concentrations in model bile. J Lipid Res 1991; 32: 1501–12
  • Harvey P RC, Sömjen G, Lichtenberg M S., Petrunka C, Gilat T, Strasbcrg S M. Nucleation of cholesterol from vesicles isolated from bile of patients with and without cholesterol gallstones. Biochim Biophys Acta 1987; 921: 198–204
  • Halpern Z, Dudley M A., Lynn M P., Nader J M., Breuer A C., Holzbach R T. Vesicle aggregation in model systems of supersaturated bile: relation to crystal nucleation and lipid composition of the vesicular phase. J Lipid Res 1986; 27: 295–306
  • Bennion U, Grundy S M. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975; 56: 996–1011
  • Vlahcevic Z R., Cooper Bell C, Jr., Buhac I, Farrar J T., Swell L. Diminished bile acid pool size in patients with gallstones. Gastroenterology 1970; 59: 165–73
  • Nilsell K, Angelin B, Liljeqvist L, Einarsson K. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease: evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 1985; 89: 287–93
  • Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B. Estrogen-induced gallstone formation in males: relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 1989; 84: 811–6
  • Schwartz C C., Berman M, Vlahcevic Z R., Halloran L G., Gregory O H., Swell L. Mulricompartmental analysis of cholesterol metabolism in man. J Clin Invest 1978; 61: 408–23
  • Mitchell J C., Stone B G., Logan G M., Duane W C. Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 1991; 32: 1143–9
  • Brown M S., Goldstein J L. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34–47
  • Heaton K W., Emmett P M., Symes C L., Braddon F EM. An explanation for gallstones in normal-weight women–slow intestinal transit. Lancet 1993; 341: 8–10
  • Marcus S N., Heaton K W. Deoxycholic acid and the pathogenesis of gallstones. Gut 1988; 29: 522–33
  • Hill G L., Mair W SJ, Goligher J C. Gallstones after ileostomy and ileal resection. Gut 1975; 16: 932–6
  • Davis R A., Hyde P M., Kuan J W., Malone-McNeal M, Arch-ambault-Schexnayder J. Bile acid secretion by cultured rat hepa-tocytes: regulation by cholesterol availability. J Biol Chem 1983; 258: 3661–7
  • Pandak W M., Vlahcevic Z R., Heuman D M., Hylemon P B. Regulation of bile acid synthesis. Inhibition of conversion of 7-dehydrocholesterol to cholesterol is associated with down-regulation of cholesterol 7ar-hydroxylase activity and inhibition of bile acid synthesis. J Lipid Res 1990; 31: 2149–58
  • Mok H YI, von Bergmann K, Grundy S M. Regulation of pool size of bile acids in man. Gastroenterology 1977; 73: 684–90
  • Dowling R H., Bell G D., White J. Lithogenic bile in patients with ileal dysfunction. Gut 1972; 13: 415–20
  • Baker A L., Kaolan M M., Norton R A., Patterson J F. Gallstones in inflammatory bowel disease. Am J Dig Dis 1974; 19: 109–12
  • Myant N B., Mitropoulos K A. Cholesterol 7-alpha-hydroxylase. J Lipid Res 1977; 18: 135–53
  • Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985; 313: 277–82
  • Reihner E, Angelin B, Bjorkhem I, Einarsson K. Hepatic cholesterol metabolism in cholesterol gallstone disease. J Lipid Res 1991; 32: 469–75
  • Miettinen T A., Kesaniemi Y A., Jarvinen H, Hastbacka J. Cholesterol precursor sterols plant sterols and cholcstanol in human bile and gallstones. Gastroenterology 1986; 90: 858–64
  • Kesaniemi Y A., Koskenvuo M, Vuoristo M, Miettinen T A. Biliary lipid composition in monozygotic and dizygotic pairs of twins. Gut 1989; 30: 1750–6
  • Miettinen T A. Impact of apo E phenotype on the regulation of cholesterol metabolism. Ann Med 1991; 23: 181–6
  • Holzbach R T., Marsh M, Olszewski M, Holan K R. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest 1973; 52: 1467–79
  • Sedaghat A, Grundy S M. Cholesterol crystals and the formation of cholesterol gallstones. N Engl J Med 1980; 302: 1274–7
  • Sedaghat A, Kesaniemi A, Grundy S M. Cholesterol crystals– a crucial link in formation of cholesterol gallstones. Falk Symposium 33. Bile acids and cholesterol in health and disease, G Paumgart-Ner, A Stiehl, W Gerok. MTP Press Limited, Boston 1983; 43–53
  • Kesäniemi Y A., Grundy S M. Clofibrate caloric restriction super-saturation of bile and cholesterol crystals. Scand J Gastroenterol 1983; 18: 897–902
  • van Erpecum K J., van Berge Henegouwen G P., Stoelwinder B, Schmidt Y MG, Willekens F LH. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients. Hepatology 1990; 11: 1–6
  • Ramond M-J, Dumont M, Belghiti J, Erlinger S. Sensitivity and specificity of microscopic examination of gallbladder bile for gallstone recognition and identification. Gastroenterology 1988; 95: 1339–43
  • Holan K R., Holzbach R T., Hermann R E., Cooperman A M., Claffey W J. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611–7
  • Busch N, Matiuck N, Sahlin S, Holzbach R T. Inhibition and promotion of cholesterol crystallization by protein fractions from normal human gallbladder bile. J Lipid Res 1991; 32: 695–702
  • Gallinger S, Harvey P RC, Petrunka C N., Ilson R G., Strasberg S M. Biliary proteins and the nucleation defect in cholesterol cholelithiasis. Gastroenterology 1987; 92: 867–75
  • Gallinger S, Taylor R D., Harvey P RC, Petrunka C N., Strasberg S M. Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology 1985; 89: 648–58
  • Groen A K., Ottenhoff R, Jansen P LM, van Marie J, Tytgat G NJ. Effect of cholesterol nucleation-promoting activity on cholesterol solubilization in model bile. J Lipid Res 1989; 30: 51–8
  • Groen A K., Noordam C, Drapers J AG, Egbers P, Jansen P LM, Tytgat G NJ. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease. Hepatology 1990; 11: 525–33
  • Harvey P RC, Upadhya A, Strasberg S M. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991; 266: 13996–4003
  • Abei M, Kawczak P, Nuutinen H, Langnas A, Svanik J, Holzbach R T. Isolation and characterization of a cholesterol crystallization-promoter from human bile. Gastroenterology 1993; 104: 539–48
  • Lee T J., Smith B F. Bovine gallbladder mucin promotes cholesterol crystal nucleation from cholesterol-transporting vesicles in supersaturated model bile. J Lipid Res 1989; 30: 491–98
  • Busch N, Tokumo H, Holzbach R T. Sensitive method for determination of cholesterol crystal growth using model solutions of supersaturated bile. J Lipid Res 1990; 31: 1903–9
  • Lee S P., Carey M C., LaMont J T. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981; 211: 1429–32
  • Lee S P., LaMont J T., Carey M C. The role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones: studies in the prairie dog. J Clin Invest 1981; 67: 1712–23
  • Holzbach R T., Kibe A, Thiel E, Howell J H., Marsh M, Hermann R E. Biliary proteins: unique inhibitors of cholesterol crystal nucleation in human gallbladder bile. J Clin Invest 1984; 73: 35–45
  • Kibe A, Holzbach R T., LaRusso N F., Mao S JT. Inhibition of cholesterol crystal formation of apolipoproteins A-I and A-II in model systems of supersaturated bile: implications for gallstone pathogenesis in man. Science 1984; 225: 514–6
  • Ohya T, Schwarzendrube J, Busch N, Gresky S, Chandler K, Takabayashi A, et al. Isolation of a human biliary glycoprotein inhibititor of cholesterol crystallization. Gastroenterology 1993; 104: 527–38
  • Shiffman M L., Sucerman H J., Kellum J M., Moore E W. Calcium in human gallbladder bile. J Lab Clin Med 1992; 120: 875–84
  • Gleeson D, Hood K A., Murphy G M., Dowling R H. Calcium and carbonate ion concentration in gallbladder and hepatic bile. Gastroenterology 1992; 102: 1707–16
  • Magnuson T H., Lillemoe K D., Zarkin B A., Pitt H A. Patients with uncomplicated cholelithiasis cidify bile normally. Dig Dis Sci 1992; 37: 1517–22
  • Doty J E., Pitt H A., Kuchenbecker S L., DenBesten L. Impaired gallbladder emptying before gallstone formation in the prairie dog. Gastroenterology 1983; 85: 168–74
  • Yau W M., Makhlouf G M., Edwards L E., Farrar J T. Mode of action of cholecystokinin and related peptides on gallbladder muscle. Gastroenterology 1973; 65: 451–6
  • Jebbink M CW, Masclee A AM, Van der Kleij F GH, Schipper J, Rovati L C., Jansen J BMJ, et al. Effects of loxiglumide and atropine on erythromycin-induced reduction of gallbladder volume in human subjects. Hepatology 1992; 16: 937–42
  • Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, et al. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992; 22: 827–34
  • Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990; 99: 1779–85
  • Behar J, Lee K Y., Thompson W R., Biagani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989; 97: 1479–84
  • Løveit T, Osnes M, Aune S, Larsen S. Studies of the chole-dochoduodenal sphincter in patients with and without juxta-papillary duodenal diverticula. Scand J Gastroenterol 1980; 15: 875–80
  • Osnes M, Løtveit T, Larsen S, Aune S. Duodenal diverticula and biliary calculi. Scand J Gastroenterol 1981; 16: 103–7
  • Løtveit T, Osnes M, Aune S. Bacteriological studies of common duct bile in patients with gallstone disease and juxtapapillary duodenal diverticula. Scand J Gastroenterol 1978; 13: 93–5
  • Lotveit T, Osnes M, Larsen S. Recurrent biliary calculi. Duodenal diverticula as a predisposing factor. Ann Surg 1982; 196: 30–2
  • Skar V, Skar A G., Osnes M. The duodenal bacterial flora in the region of papilla of vater in patients with and without duodenal diverticula. Scand J Gastroenterol 1989; 24: 649–56
  • Juvonen T, Kairaluoma M I., Malinen H, Niemela O. Extracellular matrix proteins in human bile in symptomatic gallstone disease. Connect Tiss Res 1993; 29: 171–80
  • Juvonen T, Kervinen K, Kairaluoma M I., Lajunen L HJ, Kesäniemi Y A. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993; 104: 1806–13
  • Mahley R W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.